CLINICAL_TRIALS
trial_result
· 2010-10-26
Clinical Trial Update: CT 327 in the Treatment of Atopic Dermatitis [Phase 2]
Summary
A Phase 2 trial of CT 327 for mild to moderate atopic dermatitis has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Creabilis SA | Conditions: Mild to Moderate Atopic Dermatitis | Phase 2 | Status: TERMINATED